Trexquant Investment’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-105,288
Closed -$422K 1539
2022
Q3
$422K Buy
105,288
+91,416
+659% +$693K 0.01% 880
2022
Q2
$157K Buy
13,872
+3,505
+34% +$42K 0.01% 1402
2022
Q1
$168K Buy
+10,367
New +$266K 0.01% 1230

Other funds holding NBP

Trexquant Investment's NBP Position: Q4 2022 in Review

Trexquant Investment sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2022, closing a stake of 105,288 shares — an estimated $422K sold.

Trexquant Investment first reported a position in NBP in Q1 2022 and held it in 3 quarters. The position peaked at $422K in Q3 2022. 69 funds tracked by Wall St. Rank hold NBP as of Q4 2022.

  • Trexquant Investment reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Trexquant Investment sold 105,288 NovaBridge Biosciences American Depositary Shares shares in Q4 2022, an estimated $422K.
  • Trexquant Investment first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2022 and held it in 3 quarters.
  • Trexquant Investment's NovaBridge Biosciences American Depositary Shares position peaked at $422K in Q3 2022.
  • 69 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2022.

Based on Trexquant Investment's 13F filing for Q4 2022, filed 13 Feb 2023.